Guy van Meter
Corporate Officer/Principal bij Adimab LLC
Profiel
Guy van Meter is currently the Vice President & Head-Business Development at Adimab LLC since 2012.
Prior to his current position, he held the role of Head-Business Development & Strategic Alliances at Pfizer Inc. and Head-Business Development & Technology Licensing at Dyax Corp.
Mr. van Meter completed his undergraduate degree at Babson College.
Actieve functies van Guy van Meter
| Bedrijven | Functie | Begin |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - |
Eerdere bekende functies van Guy van Meter
| Bedrijven | Functie | Einde |
|---|---|---|
| DYAX CORP. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van Guy van Meter
| Babson College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
